ABVC BIOPHARMA, INC. - 10-Q Filing
ABVC BioPharma reported a net loss of $1.56 million for the three months ended March 31, 2026, compared to a net loss of $842 thousand in the same period last year. The company's cash and equivalents decreased from $681 thousand at December 31, 2025, to $140 thousand as of March 31, 2026.
Tickers: $ABVC